Download full report with analyst certification and important disclosures
Nov 13 2024, 12:32 GMT
Dole plc
Healthy Q3 results; FY24 EBITDA guidance upgraded
DAVY VIEW
Dole’s adjusted EBITDA delivery remained healthy in Q3-24, driven in part by a strong performance in the Diversified Fresh Produce Americas and ROW segment. Given its strong year-to-date performance and positive Q4-24 outlook, management has further increased its FY24 adjusted EBITDA guidance range to “at least” $380m (previously: “at least” $370m). At first look, we envisage modest upside to our forecasts.
